Literature DB >> 19437457

Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden.

Henrik Ohlsson1, Juan Merlo.   

Abstract

PURPOSE: Therapeutic traditions at health care practices (HCPs) influence physicians' adherence to prescription guidelines for specific drugs, however, it is not known if such traditions affect all kinds of prescriptions or only specific types of drug. Our goal was to determine whether adherence to prescription guidelines is a common trait of HCPs or dependent on drug type.
METHODS: We fitted separate multi-level logistic regression models to all patients in the Skåne region who received a prescription for a statin drug (ATC: C10AA, n = 6232), an agent acting on the renin-angiotensin system (ATC: C09, n = 7222) or a proton pump inhibitor (ATC: A02BC, n = 11 563) at 198 HCPs from July 2006 to December 2006.
RESULTS: There was a high clustering of adherence to prescription guidelines at HCPs for the different drug types (MOR(agents acting on the renin-angiotensin system) = 4.72 [95% CI: 3.90-5.92], MOR(Statins) = 2.71 [95% CI: 2.23-3.39] and MOR(Proton pump inhibitors) = 2.16 [95% CI: 1.95-2.45]). Compared with HCPs with low adherence to guidelines in two drug types, those HCPs with the highest level of adherence for these two drug types also showed a higher probability of adherence for the third drug type.
CONCLUSION: Physicians' decisions to follow prescription guidelines seem to be influenced by therapeutic traditions at the HCP. Moreover, these therapeutic traditions seem to affect all kinds of prescriptions. This information can be used as basis for interventions to support rational and cost-effective medication use. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19437457     DOI: 10.1002/pds.1767

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  7 in total

1.  Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database.

Authors:  Per Hjerpe; Henrik Ohlsson; Ulf Lindblad; Kristina Bengtsson Boström; Juan Merlo
Journal:  Eur J Clin Pharmacol       Date:  2010-12-29       Impact factor: 2.953

2.  Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional study.

Authors:  Daniel Carlzon; Lena Gustafsson; Anna L Eriksson; Karin Rignér; Anders Sundström; Susanna M Wallerstedt
Journal:  BMC Clin Pharmacol       Date:  2010-02-15

3.  Change in antihypertensive drug prescribing after guideline implementation: a controlled before and after study.

Authors:  Raija Sipilä; Arja Helin-Salmivaara; Maarit Jaana Korhonen; Eeva Ketola
Journal:  BMC Fam Pract       Date:  2011-08-17       Impact factor: 2.497

4.  Clinical factors associated with statins prescription in acute ischemic stroke patients: findings from the Lombardia Stroke Registry.

Authors:  Isabella Canavero; Anna Cavallini; Patrizia Perrone; Mauro Magoni; Lucia Sacchi; Silvana Quaglini; Giordano Lanzola; Giuseppe Micieli
Journal:  BMC Neurol       Date:  2014-03-21       Impact factor: 2.474

5.  Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.

Authors:  Jianhua Wu; Shihua Zhu; Guiqing Lily Yao; Mohammed A Mohammed; Tom Marshall
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

6.  Bad apples or spoiled barrels? Multilevel modelling analysis of variation in high-risk prescribing in Scotland between general practitioners and between the practices they work in.

Authors:  Bruce Guthrie; Peter T Donnan; Douglas J Murphy; Boikanyo Makubate; Tobias Dreischulte
Journal:  BMJ Open       Date:  2015-11-06       Impact factor: 2.692

7.  The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit.

Authors:  Lesley Meng; Krzysztof Laudanski; Mariana Restrepo; Ann Huffenberger; Christian Terwiesch
Journal:  Healthcare (Basel)       Date:  2021-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.